UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent.

Abstract

The Food and Drug Administration recently cleared silver diamine fluoride for reducing tooth sensitivity. Clinical trials document arrest and prevention of dental caries by silver diamine fluoride. This off-label use is now permissible and appropriate under U.S. law. A CDT code was approved for caries arresting medicaments for 2016 to facilitate documentation and billing. We present a systematic review, clinical indications, clinical protocol and consent procedure to guide application for caries arrest treatment.

• Authors: Jeremy A Horst, Hellene Ellenikiotis, Peter L Milgrom
• Journal: Journal of the California Dental Association (J Calif Dent Assoc) Vol. 44 Issue 1 Pg. 16-28 (Jan 2016) ISSN: 1043-2256 [Print] United States
• PMID: 26897901 (Publication Type: Journal Article)

Chemical References

• Cariostatic Agents
• Dentin Desensitizing Agents
• Fluorides, Topical
• Quaternary Ammonium Compounds
• Silver Compounds
• silver diamine fluoride

Topics

• Cariostatic Agents (administration & dosage, therapeutic use)
• Clinical Protocols
• Dental Caries (prevention & control)
• Dentin Desensitizing Agents (therapeutic use)
• Fluorides, Topical
• Humans
• Off-Label Use (legislation & jurisprudence)
• Quaternary Ammonium Compounds (administration & dosage, therapeutic use)
• San Francisco
• Silver Compounds
• Systematic Reviews as Topic
• Tooth Remineralization (methods)
• United States
• United States Food and Drug Administration